Simon Plyte
Company: BIOMUNEX Pharmaceuticals
Job title: Chief Scientific Officer
Seminars:
MAIT Engagers: Potent & Safer Immune Cell Engagers to Treat Solid Tumors 3:45 pm
Improving the safety profile of T-cell engagers by selectively targeting MAIT cells MAIT engagers do not activate regulatory T-cells and restrict cytokine release Leveraging human ex vivo data (tumour / organoids) to demonstrate the potential to treat cancerRead more
day: Day 2